Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Caen
Region Stockholm
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Assistance Publique Hopitaux De Marseille
Nordsjaellands Hospital
Weill Medical College of Cornell University
Centre Hospitalier Universitaire, Amiens
Janssen Research & Development, LLC